The average relative dose intensity of R‐CHOP is an independent factor determining favorable overall survival in diffuse large B‐cell lymphoma patients

The prognosis of diffuse large B‐cell lymphoma (DLBCL) patients depends on lymphoma‐ and patient‐related risk factors and is best estimated by the international prognostic index (IPI). The aim of the study was to determine whether the average relative dose intensity (ARDI) of an anthracycline‐contai...

Descripción completa

Detalles Bibliográficos
Autores principales: Długosz‐Danecka, Monika, Szmit, Sebastian, Ogórka, Tomasz, Skotnicki, Aleksander B., Jurczak, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434223/
https://www.ncbi.nlm.nih.gov/pubmed/30740919
http://dx.doi.org/10.1002/cam4.2008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434223/
https://www.ncbi.nlm.nih.gov/pubmed/30740919
http://dx.doi.org/10.1002/cam4.2008

Ejemplares similares